(VIANEWS) – RUBIS (RUI.PA), RYANAIR HOLD. PLC (RYA.IR), SPAREBANKEN ØST (SPOG.OL) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. RUBIS (RUI.PA)
44.6% sales growth and 12.27% return on equity
Rubis engages in the operation of bulk liquid storage facilities and distribution of petroleum products in Europe, Africa, and the Caribbean. The company operates in two divisions, Retail & Marketing and Support & Services, It operates terminals that provide bulk liquid storage facilities for petroleum products, chemical products, biofuels, fertilizers, molasses, edible oils, and agri-food products; and trades in and distributes fuels, liquefied gases, bitumen, fuel oil, aviation and marine fuel, and lubricants, as well as butane and propane. The company also provides infrastructure, transportation, supply, and services for supporting the development of downstream distribution and marketing business. It serves stations, private individuals, industrial professionals, public works, energy distribution professionals, supermarkets, oil companies, chemical and petrochemical companies, agricultural cooperatives, and traders, as well as services, transportation, hotel, aviation, marine, and other industries Rubis was founded in 1990 and is headquartered in Paris, France.
Earnings Per Share
As for profitability, RUBIS has a trailing twelve months EPS of €2.72.
PE Ratio
RUBIS has a trailing twelve months price to earnings ratio of 9.53. Meaning, the purchaser of the share is investing €9.53 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.27%.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Jun 14, 2022, the estimated forward annual dividend rate is 1.86 and the estimated forward annual dividend yield is 7.14%.
Yearly Top and Bottom Value
RUBIS’s stock is valued at €25.91 at 06:20 EST, way below its 52-week high of €29.34 and way above its 52-week low of €20.74.
Volume
Today’s last reported volume for RUBIS is 66640 which is 60.02% below its average volume of 166720.
Sales Growth
RUBIS’s sales growth is 44.6% for the ongoing quarter and 44.6% for the next.
2. RYANAIR HOLD. PLC (RYA.IR)
38.7% sales growth and 24.39% return on equity
Ryanair Holdings plc, together with its subsidiaries, provides scheduled-passenger airline services in Ireland, the United Kingdom, Italy, Spain, Germany, and other European countries. It is also involved in the provision of various ancillary services, such as non-flight scheduled and Internet-related services; in-flight sale of beverages, food, duty-free, and merchandise; and marketing of car hire and accommodation services, and travel insurance through its website and mobile app. In addition, the company offers aircraft and passenger handling, ticketing, and maintenance and repair services; and markets car parking, fast-track, airport transfers, attractions, and activities on its website and mobile app, as well as sells gift vouchers. As of June 30, 2022, it had a principal fleet of approximately 483 Boeing 737 aircrafts and 29 Airbus A320 aircrafts; and offered approximately 3,000 short-haul flights per day serving approximately 225 airports. Ryanair Holdings plc was founded in 1985 and is headquartered in Swords, Ireland.
Earnings Per Share
As for profitability, RYANAIR HOLD. PLC has a trailing twelve months EPS of €-0.58.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 24.39%.
Moving Average
RYANAIR HOLD. PLC’s worth is above its 50-day moving average of €14.28 and way higher than its 200-day moving average of €12.85.
Sales Growth
RYANAIR HOLD. PLC’s sales growth for the next quarter is 38.7%.
3. SPAREBANKEN ØST (SPOG.OL)
20.9% sales growth and 6.25% return on equity
Sparebanken Øst operates as a savings bank in Eastern Norway. The company offers financial products, such as savings, credit, and payment products; mortgages on homes; and debenture financing for second-hand cars, as well as services in the areas of financing, savings and investment, and money-transfer. It also distributes insurance, fund shares, interest rate hedging, and currency, as well as operates, manages, leases, and sells real estate properties. The company was founded in 1843 and is headquartered in Drammen, Norway.
Earnings Per Share
As for profitability, SPAREBANKEN ØST has a trailing twelve months EPS of kr6.62.
PE Ratio
SPAREBANKEN ØST has a trailing twelve months price to earnings ratio of 7.85. Meaning, the purchaser of the share is investing kr7.85 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.25%.
Sales Growth
SPAREBANKEN ØST’s sales growth is 10% for the ongoing quarter and 20.9% for the next.
Moving Average
SPAREBANKEN ØST’s value is above its 50-day moving average of kr48.66 and higher than its 200-day moving average of kr48.97.
Volume
Today’s last reported volume for SPAREBANKEN ØST is 5279 which is 64.5% below its average volume of 14874.
4. RANA GRUBER (RANA.OL)
20.1% sales growth and 70.08% return on equity
Rana Gruber AS engages in the mining, production, and sale of iron ore concentrate primarily to steel producers and the chemical industry. It excavates, processes, and sells iron oxide in the form of hematite, magnetite, and iron oxide pigments. The company also produces and sells micronized iron oxides and other dissemination of iron ore for paint manufactures, as well as building and automotive industries. It offers its products under the Rana Gruber Concentrates and Colorana brands. The company also exports its products worldwide. Rana Gruber AS was founded in 1937 and is headquartered in Mo i Rana, Norway.
Earnings Per Share
As for profitability, RANA GRUBER has a trailing twelve months EPS of kr7.3.
PE Ratio
RANA GRUBER has a trailing twelve months price to earnings ratio of 8.48. Meaning, the purchaser of the share is investing kr8.48 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 70.08%.
5. MELEXIS (MELE.BR)
18.6% sales growth and 45.26% return on equity
Melexis NV designs, develops, tests, and markets advanced integrated semiconductor devices primarily for the automotive industry in Europe, the Middle-East, Africa, the Asia Pacific, and North and Latin America. The company provides magnetic position, latch and switch, current, inductive position, tire monitoring, temperature, optical, pressure, and speed sensor ICs. It also offers embedded motor driver, fan and pump, LED, and pre driver ICs; and LIN/CAN system basis, NFC/RFID, radio-frequency receiver and transmitter, and switch controller ICs. The company was founded in 1988 and is headquartered in Ieper, Belgium. Melexis NV is a subsidiary of Xtrion N.V.
Earnings Per Share
As for profitability, MELEXIS has a trailing twelve months EPS of €1.89.
PE Ratio
MELEXIS has a trailing twelve months price to earnings ratio of 55.33. Meaning, the purchaser of the share is investing €55.33 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 45.26%.
Volume
Today’s last reported volume for MELEXIS is 5977 which is 77.1% below its average volume of 26101.
Yearly Top and Bottom Value
MELEXIS’s stock is valued at €104.80 at 06:20 EST, below its 52-week high of €105.50 and way above its 52-week low of €63.05.
Earnings Before Interest, Taxes, Depreciation, and Amortization
MELEXIS’s EBITDA is 4.84.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on May 10, 2023, the estimated forward annual dividend rate is 4.4 and the estimated forward annual dividend yield is 4.26%.
6. BOIRON (BOI.PA)
17.2% sales growth and 9.87% return on equity
Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary, proprietary, branded homeopathic medicines. Its branded homeopathic medicines include Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for adjunctive local treatment of benign trauma in the absence of open wounds; Camilia for the treatment of teething problems for babies; and Sédatif PC to treat anxiety and emotional, and minor sleep disorders. The company's homeopathic medicines also comprise Coryzalia for the treatment of cold symptoms and rhinitis; Homéoptic to treat eye discomfort and irritation due to various causes for adults and children; and Homéovox for vocal disorders. In addition, it provides dietary supplement; Dermoplasmine stick, baume, and mousse to treat dry lips and skin; Mag' Nuit, a formula to fall asleep; Arnitrosium for joint pain; Castor Equi Boiron ointment for treatment of cracked skin; and Storinyl, a syrup to treat colds. Further, it offers herbal medicines, such as Canephron to increase the amount of urine and to improve urinary elimination; moisturizing baby milk; and medical devices, including a range of COVID self-tests and rapid antigenic tests. The company offers its products through distribution centers, pharmacies, pharmacy chains, wholesalers, grocery and drugstores, health food stores, and online retail. Boiron SA was founded in 1932 and is headquartered in Messimy, France.
Earnings Per Share
As for profitability, BOIRON has a trailing twelve months EPS of €2.93.
PE Ratio
BOIRON has a trailing twelve months price to earnings ratio of 14.4. Meaning, the purchaser of the share is investing €14.4 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.87%.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Jun 1, 2022, the estimated forward annual dividend rate is 0.95 and the estimated forward annual dividend yield is 2.28%.
7. EQUASENS (EQS.PA)
11.3% sales growth and 28.59% return on equity
Equasens Société anonyme provides various IT solutions for the healthcare sector in Europe. It offers LGPI global services and OffiCentral solutions for managing pharmacies and their networks; OffiMSS, OffiSecure, OffiProtect, OffiPass, OffiSeen, OffiCash, Offizzy, and OffiLocker solutions for pharmacists' business processes; and solutions for energizing the customer relationship with pharmacists comprising OffiTag, OffiTouch, OffiMédia, OffiConnect, automation systems, and customer loyalty programs. The company also provides My Pilot, an analytics and management tool; OffiLearning, an e-learning tool; and solutions for patient support and advice, such as compliance monitoring software, Multimeds, Automeds, and OffiTéléconsult, as well as pharmaceutical record and shared medical record services. In addition, it offers a ULTIMATE, a system combining optimized pharmacy management and improved patient support; FARMACLICK, a protocol for communications between pharmacies and wholesalers-distributors; DIFARM, a solution for wholesalers-distributors; PHARE, a retail management tool; SOPHIA, a pharmacy management application; OffiMédia POS display; eNephro to enhance the care of chronic renal failure patients; and TPE Pilot, a web-based application that simplifies the management and sharing of patient education programs. Further, the company provides NOVIACARE; CARELIB Domicile; CARELIB EHPAD; KAPELSE solutions; TITAN solutions; ANTHADINE software and MOBISOINS mobile tool; MICROSOINS, an in-home nursing care solution; and LOGICLIC. Additionally, it offers AXIGATE solutions to manage the entire patient care pathway; CHORUS platform; medical telesecretarial services for healthcare professionals; and equipment lease financing solutions. The company was incorporated in 1996 and is based in Villers-les-Nancy, France. Equasens Société anonyme is a subsidiary of Marque Verte Sante.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 28.59%.
Sales Growth
EQUASENS’s sales growth is 11.3% for the present quarter and 11.3% for the next.
Moving Average
EQUASENS’s value is under its 50-day moving average of €77.40 and below its 200-day moving average of €76.13.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Jun 30, 2022, the estimated forward annual dividend rate is 1.05 and the estimated forward annual dividend yield is 1.34%.
